SCHEMBL23697271

SCHEMBL23697271

Clc1ccc2c(c1)Sc1ccccc1C2(c1ccccc1)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 5/20 0.44
BCHE P06276 4/20 0.44
NOX1 Q9Y5S8 1/20 0.44
MAP3K14 Q99558 1/20 0.36
HPGD P15428 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
GPR84 Q9NQS5 2/20 0.35
PDK2 Q15119 1/20 0.34
MTOR P42345 1/20 0.33
TP53 P04637 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
NFKB1 P19838 1/20 0.33
MAPK1 P28482 1/20 0.33
CYP2C19 P33261 1/20 0.33
THPO P40225 1/20 0.33
MLNR O43193 1/20 0.33
NR1I2 O75469 1/20 0.33
ESR1 P03372 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23028874 0.85 PDK2 (0.38) ACHEBCHENOX1MAP3K14HPGD
SCHEMBL23208383 0.84 PDK2 (0.41) ACHEBCHENOX1HPGDL3MBTL1
SCHEMBL28267231 0.84 NOX1 (0.41) ACHEBCHENOX1L3MBTL1CYP1A2
SCHEMBL23372318 0.83 PDK2 (0.44) ACHEBCHENOX1HPGDL3MBTL1
SCHEMBL16787353 0.81 CYP1A2 (0.40) ACHEBCHENOX1HPGDL3MBTL1
SCHEMBL21743587 0.80 MEN1 (0.38) ACHEBCHENOX1HPGDGPR84
SCHEMBL21743573 0.80 OPRM1 (0.34) ACHEBCHENOX1PDK2CYP1A2
SCHEMBL23697030 0.79 BCHE (0.46) ACHEBCHENOX1HPGDL3MBTL1
SCHEMBL23028927 0.77 BCHE (0.40) ACHEBCHENOX1HPGDL3MBTL1
SCHEMBL23028877 0.77 MEN1 (0.36) ACHEBCHENOX1HPGDL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183201-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE HAVING SAME DUK SAN NEOLUX CO., LTD. (KR) 2023-06-15 US disclosed
US-20230183201-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE HAVING SAME DUK SAN NEOLUX CO., LTD. (KR) 2023-06-15 US disclosed
WO-2021149998-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE HAVING SAME 덕산네오룩스 주식회사 2021-07-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183201-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE HAVING SAME ORAI2, OR10J3, OR51E2 ACHE 120/4885BCHE 1196/4885NOX1 538/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.